SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001711279-23-000037
Filing Date
2023-05-19
Accepted
2023-05-19 17:05:17
Documents
15
Period of Report
2023-05-19
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K krys-20230519.htm   iXBRL 8-K 44512
2 EX-99.1 a991pressreleasekrystalbio.htm EX-99.1 33283
3 EX-99.2 exhibit992toformfdaapprova.htm EX-99.2 7846
7 image_0.jpg GRAPHIC 143627
  Complete submission text file 0001711279-23-000037.txt   423800

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krys-20230519.xsd EX-101.SCH 1914
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krys-20230519_lab.xml EX-101.LAB 22164
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krys-20230519_pre.xml EX-101.PRE 11598
9 EXTRACTED XBRL INSTANCE DOCUMENT krys-20230519_htm.xml XML 9791
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 23941377
SIC: 2836 Biological Products, (No Diagnostic Substances)